Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:06:54 2026-06-17 EDT			5-day change	1st Jan Change
159.00 ^EUR	-1.94%		-1.49%	-7.48%

06-17	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade	MT
06-17	Morgan Stanley Upgrades Charles River Laboratories International to Overweight From Equal Weight, Adjusts PT to $220 From $185	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LONZA GROUP AG	43.51B		AAA
REVOLUTION MEDICINES, INC.	33.29B	-	B	-		-
BEONE MEDICINES AG	29.34B		-
IQVIA HOLDINGS INC.	29.9B		AAA
CELLTRION, INC.	25.42B		A
ASCENDIS PHARMA A/S	14.36B	-	-	-		-		-
MEDPACE HOLDINGS, INC.	13.18B		BBB
EUROFINS SCIENTIFIC SE	12.72B		AA
IONIS PHARMACEUTICALS, INC.	12.08B	-	A	-		-
ICON PUBLIC LIMITED COMPANY	10.99B		AAA
TEMPUS AI, INC.	9.08B		A			-
BIO-TECHNE CORPORATION	8.77B		AA
REGENCELL BIOSCIENCE HOLDINGS LIMITED	8.29B	-	-	-	-	-	-	-
ABIVAX	7.73B	-	BBB	-		-
QIAGEN N.V.	7.7B		AAA
ALKERMES PLC	7.35B		A
PRAXIS PRECISION MEDICINES, INC.	7.17B	-	B	-		-
PROTAGONIST THERAPEUTICS, INC.	7.12B		BB			-
KYMERA THERAPEUTICS, INC.	7.19B	-	BBB	-		-
Average	15.54B		A
Weighted average by Cap.			A